We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Encompass Health Flexes Its Muscle: Margins Widen as Volumes Climb
Read MoreHide Full Article
Key Takeaways
EHC's occupancy rose from 72.1% in 2023 to 77.7% in the first half of 2025.
Patient discharges climbed 8.7% in 2023, 8.3% in 2024, and 6.8% in early 2025.
Adjusted net margin improved from 7.7% in 2023 to 9.7% in the first half of 2025.
Encompass Health Corporation (EHC - Free Report) is proving that smart expansion and operational discipline can deliver meaningful results. Fueled by an aging population and growing demand for inpatient rehabilitation, volumes keep rising while the company has steadily widened its margins.
To meet the influx of patients, Encompass Health has been actively expanding its hospital footprint and adding new beds. Despite a shorter average length of stay, occupancy rates are trending upward, from 72.1% in 2023 to 74.6% in 2024 and 77.7% average through the first half of 2025. Patient discharges also highlight the growth story, climbing 8.7% in 2023, 8.3% in 2024 and 6.8% in the first six months of 2025.
Meanwhile, the company has leveraged its pricing power, with revenues per visit soaring 27%, 40.8% and 68% across the same periods. Net operating revenues witnessed lower end of double-digit growth over the previous couple of years, as well as the first two quarters of 2025.
Operational efficiency is another key driver. Investments in technology, smarter staffing strategies and tighter cost controls have helped the company contain labor expenses and enhance profitability. Adjusted net margin rose from 7.7% in 2023 to 8.4% in 2024, reaching 9.7% on average in the first half of 2025.
With patient demand accelerating and efficiency gains compounding, Encompass Health looks well-positioned to sustain its growth momentum and keep flexing its financial muscle. The Zacks Consensus Estimate for its 2025 earnings implies an 18.3% rise year over year.
Image Source: Zacks Investment Research
How Are Other Medical Stocks Faring?
Peers like Universal Health Services, Inc. (UHS - Free Report) and Tenet Healthcare Corporation (THC - Free Report) in the Medical space are also witnessing rising revenues.
Universal Health’s revenues increased 6.6% in 2023 and 10.8% in 2024. The Zacks Consensus Estimate for 2025 indicates an 8.5% year-over-year jump to $17.2 billion. UHS is expected to sustain the momentum with growth in admissions at its acute care facilities and behavioral health care services. Meanwhile, Tenet Healthcare’s 2023 and 2024 revenues rose 7.2% and 0.6%. The consensus estimate indicates a 2.4% increase in the top line in 2025 for THC, supported by a favorable payer mix.
Encompass Health’s Price Performance and Valuation
Shares of Encompass Health have jumped 36.4% year to date compared with the industry’s growth of 10.1%.
Image Source: Zacks Investment Research
From a valuation standpoint, Encompass Health trades at a forward price-to-earnings ratio of 22.55X, higher than the industry average of 19.59X. EHC carries a Value Score of B.
Image: Bigstock
Encompass Health Flexes Its Muscle: Margins Widen as Volumes Climb
Key Takeaways
Encompass Health Corporation (EHC - Free Report) is proving that smart expansion and operational discipline can deliver meaningful results. Fueled by an aging population and growing demand for inpatient rehabilitation, volumes keep rising while the company has steadily widened its margins.
To meet the influx of patients, Encompass Health has been actively expanding its hospital footprint and adding new beds. Despite a shorter average length of stay, occupancy rates are trending upward, from 72.1% in 2023 to 74.6% in 2024 and 77.7% average through the first half of 2025. Patient discharges also highlight the growth story, climbing 8.7% in 2023, 8.3% in 2024 and 6.8% in the first six months of 2025.
Meanwhile, the company has leveraged its pricing power, with revenues per visit soaring 27%, 40.8% and 68% across the same periods. Net operating revenues witnessed lower end of double-digit growth over the previous couple of years, as well as the first two quarters of 2025.
Operational efficiency is another key driver. Investments in technology, smarter staffing strategies and tighter cost controls have helped the company contain labor expenses and enhance profitability. Adjusted net margin rose from 7.7% in 2023 to 8.4% in 2024, reaching 9.7% on average in the first half of 2025.
With patient demand accelerating and efficiency gains compounding, Encompass Health looks well-positioned to sustain its growth momentum and keep flexing its financial muscle. The Zacks Consensus Estimate for its 2025 earnings implies an 18.3% rise year over year.
How Are Other Medical Stocks Faring?
Peers like Universal Health Services, Inc. (UHS - Free Report) and Tenet Healthcare Corporation (THC - Free Report) in the Medical space are also witnessing rising revenues.
Universal Health’s revenues increased 6.6% in 2023 and 10.8% in 2024. The Zacks Consensus Estimate for 2025 indicates an 8.5% year-over-year jump to $17.2 billion. UHS is expected to sustain the momentum with growth in admissions at its acute care facilities and behavioral health care services. Meanwhile, Tenet Healthcare’s 2023 and 2024 revenues rose 7.2% and 0.6%. The consensus estimate indicates a 2.4% increase in the top line in 2025 for THC, supported by a favorable payer mix.
Encompass Health’s Price Performance and Valuation
Shares of Encompass Health have jumped 36.4% year to date compared with the industry’s growth of 10.1%.
From a valuation standpoint, Encompass Health trades at a forward price-to-earnings ratio of 22.55X, higher than the industry average of 19.59X. EHC carries a Value Score of B.
The stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.